Skip to Content


Q & A with I. Glenn Cohen (Faculty Director)
Harvard Law Today
January 31, 2018

Read the full Q&A!

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen recently announced a new collaboration, the Project on Precision Medicine, Artificial Intelligence, and the Law (PMAIL). PMAIL will provide a comparative analysis of the law and ethics of black-box personalized medicine, explaining the shortcomings of the current innovation policy landscape in Europe and the US, and providing a comprehensive examination of various policy options to better harness the potential of black-box medicine.

Professor I. Glenn Cohen, faculty director of the Petrie-Flom Center, will lead PMAIL. In a Q&A with Harvard Law Today, he discussed the center’s latest project:

​Read the full Q&A!

Read the full Q&A!

Tags

artificial intelligence   bioethics   genetics   health law policy   i. glenn cohen   innovation   international   precision medicine   regulation   research   w. nicholson price ii